VEGFA and cancer: TKIs primarily inhibit VEGF by diminishing the activity of thevascular endothelial growth factor receptor (VEGFR) tyrosine kinase [86, 87], andare currently employed in the treatment of colorectal cancer, breast cancer, andkidney cancer.